| 1 |
33782649 | Flavonoids as an Intervention for Alzheimer's Disease: Progress and Hurdles Towards Defining a Mechanism of Action. | 2021 Feb 9 |
1 |
| 2 |
30961461 | Bioavailability of naringenin chalcone in humans after ingestion of cherry tomatoes. | 2020 Oct |
1 |
| 3 |
32752084 | Preparative Separation of Flavonoids from Goji Berries by Mixed-Mode Macroporous Adsorption Resins and Effect on Aβ-Expressing and Anti-Aging Genes. | 2020 Jul 31 |
1 |
| 4 |
30935135 | Polyphenols Modulate Alzheimer's Amyloid Beta Aggregation in a Structure-Dependent Manner. | 2019 Mar 31 |
1 |
| 5 |
29953467 | The role of phenolic OH groups of flavonoid compounds with H-bond formation ability to suppress amyloid mature fibrils by destabilizing β-sheet conformation of monomeric Aβ17-42. | 2018 |
2 |
| 6 |
27766768 | Flavonoids and Their Glycosides as Anti-amyloidogenic Compounds: Aβ1-42 Interaction Studies to Gain New Insights into Their Potential for Alzheimer's Disease Prevention and Therapy. | 2017 Jan 3 |
1 |
| 7 |
27856006 | Insights into the aggregation mechanism of Aβ(25-40). | 2017 Jan |
1 |
| 8 |
28128562 | Combined in Vitro Cell-Based/in Silico Screening of Naturally Occurring Flavonoids and Phenolic Compounds as Potential Anti-Alzheimer Drugs. | 2017 Feb 24 |
1 |
| 9 |
28154265 | Inhibitory Activities of Antioxidant Flavonoids from Tamarix gallica on Amyloid Aggregation Related to Alzheimer's and Type 2 Diabetes Diseases. | 2017 |
2 |
| 10 |
25779965 | Galangin-induced down-regulation of BACE1 by epigenetic mechanisms in SH-SY5Y cells. | 2015 May 21 |
1 |
| 11 |
26092626 | Biflavonoids as Potential Small Molecule Therapeutics for Alzheimer's Disease. | 2015 |
3 |
| 12 |
24328060 | Flavonoids as therapeutic compounds targeting key proteins involved in Alzheimer's disease. | 2014 Feb 19 |
1 |
| 13 |
25383163 | Synthetic Flavonoids, Aminoisoflavones: Interaction and Reactivity with Metal-Free and Metal-Associated Amyloid-β Species. | 2014 Dec 1 |
2 |
| 14 |
24058373 | Synergistic Action of Flavonoids, Baicalein, and Daidzein in Estrogenic and Neuroprotective Effects: A Development of Potential Health Products and Therapeutic Drugs against Alzheimer's Disease. | 2013 |
1 |
| 15 |
21982844 | Flavonoids, cognition, and dementia: actions, mechanisms, and potential therapeutic utility for Alzheimer disease. | 2012 Jan 1 |
1 |
| 16 |
22437427 | Exploring the reactivity of flavonoid compounds with metal-associated amyloid-β species. | 2012 Jun 7 |
2 |
| 17 |
22762350 | Morin inhibits the early stages of amyloid β-peptide aggregation by altering tertiary and quaternary interactions to produce "off-pathway" structures. | 2012 Jul 31 |
1 |
| 18 |
21652140 | Resolution of localized small molecule-Aβ interactions by deep-ultraviolet resonance Raman spectroscopy. | 2011 Oct |
2 |
| 19 |
19931462 | Carboxymethylated-kappa-casein: a convenient tool for the identification of polyphenolic inhibitors of amyloid fibril formation. | 2010 Jan 1 |
2 |
| 20 |
20369844 | Destabilizing Alzheimer's Abeta(42) protofibrils with morin: mechanistic insights from molecular dynamics simulations. | 2010 May 11 |
1 |
| 21 |
17590240 | Epigallocatechin gallate (EGCG) suppresses beta-amyloid-induced neurotoxicity through inhibiting c-Abl/FE65 nuclear translocation and GSK3 beta activation. | 2009 Jan |
1 |
| 22 |
18295609 | Flavonols and flavones as BACE-1 inhibitors: structure-activity relationship in cell-free, cell-based and in silico studies reveal novel pharmacophore features. | 2008 May |
1 |
| 23 |
17253770 | The anti-amyloidogenic effect is exerted against Alzheimer's beta-amyloid fibrils in vitro by preferential and reversible binding of flavonoids to the amyloid fibril structure. | 2007 Feb 20 |
1 |